相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quality Threshold Clustering of Molecular Dynamics: A Word of Caution
Roy Gonzalez-Aleman et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity
William E. Ruff et al.
CELL HOST & MICROBE (2019)
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Cristina Gil-Cruz et al.
SCIENCE (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis
John-William Sidhom et al.
CANCER IMMUNOLOGY RESEARCH (2018)
The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable
Alok V. Joglekar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel et al.
SCIENCE (2018)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Luksza et al.
NATURE (2017)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
Karlo Perica et al.
ACS NANO (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+Natural Killer Cells: Data from an Observational Cohort in South Africa
Angelique Hoelzemer et al.
PLOS MEDICINE (2015)
pmx: Automated Protein Structure and Topology Generation for Alchemical Perturbations
Vytautas Gapsys et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2015)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
MHC-Ig induces memory T cell formation in vivo and inhibits tumour growth
Christian Schuetz et al.
IMMUNITY INFLAMMATION AND DISEASE (2014)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone φ, ψ and Side-Chain χ1 and χ2 Dihedral Angles
Robert B. Best et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Defining the molecular blueprint that drives CD8(+) T cell differentiation in response to infection
Brendan E. Russ et al.
FRONTIERS IN IMMUNOLOGY (2012)
Affinity Thresholds for Naive CD8+ CTL Activation by Peptides and Engineered Influenza A Viruses
Alice E. Denton et al.
JOURNAL OF IMMUNOLOGY (2011)
How a single T cell receptor recognizes both self and foreign MHC
Leremy A. Colf et al.
CELL (2007)
Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula
M Haarman et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo
C Blank et al.
JOURNAL OF IMMUNOLOGY (2005)
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells
C Blank et al.
CANCER RESEARCH (2004)
分享论文
